期刊文献+

肿瘤性贫血病人血清促红细胞生成素和睾酮水平的研究 被引量:2

Study on the serum erythropoietin and testosterone in patients with anemia of cancer
原文传递
导出
摘要 目的 研究血清促红细胞生成素 (EPO)和睾酮 (T)与肿瘤性贫血的关系。方法 用ELISA法及放射免疫法测定肿瘤性贫血病人血清EPO和T的水平 ,并与正常对照及化疗前后比较。结果 肿瘤性贫血病人血清EPO含量 (2 78± 0 73μg/ml)显著高于正常对照 (1 6 0± 0 5 6 μg/ml) ,P <0 0 1,于化疗后升高更显著 ;而血清睾酮的水平 (16 6± 7 86nmol/L)显著低于正常对照 (19 18± 9 6 9nmol/L) ,且化疗后降低更明显。结论 肿瘤性贫血病人内源性EPO水平升高 ,睾酮水平下降 。 Objective To investigate the change of serum erythropoietin and testosterone in patients with anemia of cancer.Methods Levels of EPO and testosterone were detected with the ELISA and radio immunoassay.Results Serum EPO level in anemia of cancer was 2.78±0.73μg/ml,wich was significantly higher than those in normal controls(1.60±0.56μg/ml) and increased greatly after chemotherapy.While the serum testosterone level in anemia of cancer(16.6±7.86nmol/L) reduced significantly compared with those in normal controls(19.18±9.69nmol/L).Conclusion There was a increased endogenous EPO levels with a decreased testosterone levels in patients with anemia of cancer,chemotherapy and testosterone may be effective for treatment anemia of cancer.
出处 《中国基层医药》 CAS 2004年第3期295-296,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 肿瘤性贫血 血清 促红细胞生成素 睾酮 放射免疫法 测定 Anemia of cancer Erythropoietin Testosterone
  • 相关文献

参考文献3

  • 1Malgor LA,Valsecie M,Verges E,et al.Blockade of the in vitro effects of testosterone and erythropietin on Cfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide[].Acta Physiol Pharmacol Ther Latinoam.1998
  • 2Faquin WC,Schneider TJ,Golberg MA,et al.Effect of inflammatory cytokines on hypoxia-induced erthropietin production[].Blood.1992
  • 3Ludwig H,Fritz E,et al.Anemia in cancer patients[].Seminars in Oncology.1998

同被引文献26

  • 1彭志刚,黄彦云,牛威林.成年男性白血病患者生殖内分泌的研究[J].广西医科大学学报,1995,12(4):538-539. 被引量:1
  • 2陈名声,徐焰,郝晓柯,张永生,徐威,卢宝弼.血清性激素的水平对男性肺癌患者诊断的意义[J].中国肺癌杂志,2005,8(4):300-303. 被引量:11
  • 3陆崇,刘魁凤,张凯娜,温宗秋,舒阳春,丁颖.中晚期非小细胞肺癌化疗相关性贫血临床特征分析[J].实用医学杂志,2007,23(17):2681-2682. 被引量:4
  • 4Jemal A, Thomas A, Murray T, et al. Cancer statistics [ J ]. CA Cancer J Clin,2002,52( 1 ) :23-47.
  • 5Groopman JE, Itri LM. Chemotherapy induced anemia in adults: incidence and treatment[ J ]. J Natl Cancer Inst, 1999,91 : 1616- 1634.
  • 6Keisuke AOE,Akio H,Tadashi M, et al. Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer [ J ]. Internal Medicine, 2005,44 : 800- 804.
  • 7Waters JS, OB rien ME, Ashley S. Management of anemia in pa- tients receiving chemotherapy [ J ]. J Clin Oncol, 2002,20 : 601 - 603.
  • 8Curt GA, Breitbart W,Cella D, et al. Impact of cancer related fa- tigue on the lives of patients:new findings from the fatigue coali- tion[ J]. The Oncologist,2005 ,5 :353-360.
  • 9Jacobsen PB, Thors CL, Cawley M, et al. Relation of decline in hemoglobin to cognitive functioning and fatigue during chemother- apy treatment[ J]. ProcASCO ,2002,21:386.
  • 10Celia D. The functional assessment of cancer therapy-anemia ( FACT An) scale : a new tool for the assessment of outcomes in cancer anemia and fatigue [ J ]. Semin Hematol, 1997,34 ( Suppl 2) :13.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部